8-KThe WireStrategic
Results of Operations · Reg FD Disclosure
Filed May 16, 2024 · 2y ago · Accession 0001558370-24-008337
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- NRX Pharmaceuticals, Inc.
- Ticker
- NRXP
- CIK
- 1719406
- Form type
- 8-K
- Filing date
- May 16, 2024
- Report date
- May 14, 2024
- Document
- nrxp-20240514x8k.htm
- Size
- 483 KB